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Risk of infection in primary, elective total
hip arthroplasty with direct anterior
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prospective cohort study of 1104 hips
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Abstract
Background: The direct anterior approach (DAA) is increasingly popular for hip replacement. However, the small
incision and the location near to the groin might increase the risk of periprosthetic joint infection (PJI). We asked
the questions (i) whether there is an increased risk of infection for this approach, and (ii) whether the spectrum of
microorganisms differs between patients with DAA and those with lateral transgluteal approach (LAT).
Methods: All patients operated between 08/2006 and 12/2013 were followed prospectively in an in house register.
The DAA was introduced as routine in 02/2009 at our hospital. Patients with primary elective hip replacement
without previous operations were included. Follow-up was scheduled after 6, 12 weeks and 1, 2 years. PJI was
defined according to standardized criteria.
Results: One thousand one hundred four patients were studied, 700 were operated with DAA and 404 with
LAT. No patient was lost to follow-up. PJI was diagnosed in 23/1104 (2.1 %) patients, 16 (2.3 %) in the group
with DAA, and 7 (1.7 %) in the group with LAT. Patients with infection had a higher BMI (p < 0.001) and a
higher ASA score (p < 0.001). Only patients with the DAA had exogenous PJI caused by gramnegative bacilli
(35.7 % vs 0 %, p = 0.26). In the DAA-group, the fraction of patients with polymicrobial infection was somewhat higher
than in the LAT-group (50 % vs 33 %, P = 0.64).
Conclusion: There was no increased risk of infection for the DAA.
Keywords: PJI, Direct anterior approach, Lateral transgluteal approach, Total hip arthroplasty, Prosthetic joint infection
Background
Periprosthetic joint infection (PJI) is one of the major
complications after total hip arthroplasty (THA), with a
reported incidence of 0.5 to 3 % [1]. Many factors con-
tribute to the risk of PJI, some of them can be influenced
by appropriate measures [2]. Recently, an increasing risk
of PJI has been described in the Nordic hip registers [3]
and from the US [4]. The reported infection rates
depend on the definition of infection, the awareness
of the surgeon, the quality of reporting, and the
length of follow-up. In implant registers, there might
be confounding factors, and data might be less reli-
able as compared to specific prospective infection
registration [3, 5, 6].
The surgical approach affects the posture of the pa-
tient, the effectiveness of laminar air flow and the drap-
ing [7]. In addition, skin quality including the type of the
microbiome differs at the various incision sites [8]. Thus,
the surgical approach itself might influence the rate of
PJI, as well as the spectrum of infecting microorganisms.
For the posterior and lateral approaches, such a differ-
ence could not be shown [9]. However, there is an in-
creasing interest in the direct anterior approach (DAA),
being assumed to be more anatomical and thus less
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invasive. For the DAA, the incision is closer to the groin
(Fig. 1), which is a highly colonized region.
It has been shown, that groin incision is a risk factor
for vascular graft associated infections [10]. Further-
more, aiming to shorter incisions might be a potential
risk of increased skin irritation by traction and by surgi-
cal instruments. This might cause problems with wound
healing or contamination of the implant with consecu-
tive PJI [11–13].
In our hospital, we introduced DAA according to
Matta [14] as routine in 2009 for primary elective total
hip replacement [15]. Three years after introduction we
observed a clustering of early infections caused either by
gram-negative bacilli or by multiple microorganisms
(polymicrobial). Thus, we asked the question as to
whether there is (i) an increased risk of infection for
DAA, and (ii) whether the spectrum of microorganisms
differs between patients with DAA and those with the
lateral transgluteal approach (LAT), being routine at our
hospital until 2009.
Methods
This is a retrospective observational study with pro-
spectively acquired data of a cohort from our University
affiliated academic teaching hospital with an interdiscip-
linary unit for orthopedic infections. This study was ap-
proved by the local Ethics Committee (Northwest and
Central Switzerland, EKNZ 2015–426). In accordance
with the Ethics Committee, no specific informed consent
was required.
Between 08/2006 and 12/2013, 1280 primary THA
were performed. Only elective hip replacements without
previous hip surgery were included in the study. In total,
176 hips were excluded, 86 had a hip fracture, 78 had
previous hip surgery, 11 had bone metastases, and one
had rapid destructive inflammation. Out of the 1104
included hips, 700 (63 %) were operated with DAA, and
404 with LAT (Table 1).
The lateral approach in supine position (Fig. 1) was ex-
clusively used until 3/2009, i.e. during the first 31 months
of the study. Thereafter, the DAA was introduced. The
first 100 DAA interventions were performed by 2 experi-
enced hip surgeons. Later young consultants and residents
were trained as it was standard for LAT too. After intro-
duction of DAA, 34 hips were still operated via LAT for
various reasons. Eight had previous surgery on the oppos-
ite via a lateral approach and requested the same ap-
proach. In 7 hips, DAA was not performed because of
skin irritations in the groin, in 6 because of obesity, in 4
because of severe flexion contracture or a repair of the
gluteal muscles, in 5 for teaching reasons, in one because
of hip dysplasia and a deficient acetabular roof, and in
three because no DAA trained surgeon was available.
For the DAA, the patients were postured in supine pos-
ition on a trauma table [14]. We used the direct anterior
approach (Fig. 1) according to Smith-Peterson [16] with a
split of the fascia of the tensor fascia lata and preparation
through the intramuscular plane between M. sartorius
and M. tensor fascia latae [15]. Patients operated from lat-
eral [17] were posed in supine position, the peri- and post-
operative setting was the same.
All interventions were performed in laminar airflow
without protective helmets. Patients were covered with
forced air flow blankets. Single shot antibiotic prophylaxis
(cefuroxime 1.5 g) was administered 30–60 minutes prior
to skin incision. The skin was disinfected three times with
a povidone-iodine solution (Betaseptic™, Mundipharma,
Basel, CH) for totally 5 minutes [18]. Afterwards, in the
DAA group, a plastic trauma draping (3 M, Rüschlikon,
CH) was used, around the planned skin incision, the drape
was removed and the skin was disinfected once more. The
LAT group was operated without a plastic draping. Two
pairs of gloves were used, before start of surgery the outer
pair of gloves was changed. Perioperatively, the wound
was cleaned and disinfected with a 0.1 % polyhexanide-
solution (LavaseptTM BBraun, Sempach, CH). The skin
was closed with subcutaneous and cutaneous sutures.
Sutures were removed by the family practitioner or by
the rehabilitation staff 12–14 days after surgery. Out-
patient physicians were informed to resubmit the patient
without prescribing antibiotics in case of any wound
healing disturbance (redness, dehiscence, oozing).
The most frequently used implants were spherical press-
fit cups and cemented or uncemented stems (Table 2).
Body mass index (BMI), American Society of
Anesthesiologist (ASA) score, procedure time and
blood-loss were taken from the charts. All patients were
prospectively followed in our in-house register, which
has been introduced in 1984. There was an approval of
the local ethical authorities for follow-up visits (EKNZ
Fig. 1 For the DAA (red line) a straight incision following the
proximal part of a line (dotted) between the anterior superior iliac
spine (ASIS) and the head of the fibula was made. For the LAT
(green line) a straight incision was used parallel to the femur in the
middle of the major trochanter
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2015–426). Follow-up was scheduled at 6 and 12 weeks,
and after 1, 2 and 5 years. A standardized clinical and
radiological follow-up protocol was followed, including
registration of any adverse events [15]. All patients were
seen at every follow-up by one out of 3 consultants of
the hip unit.
PJI was diagnosed according to the IDSA-guidelines
[19]. At least one of the following criteria had to be
fulfilled: (a) presence of a sinus tract, (b) visible pus
surrounding the joint without other explanation (e.g.
no crystals), (c) acute inflammation on histopatho-
logical examination (>5 neutrophils/high-power field),
(d) >4200 leukocyte per μl and/or >80 % polymorpho-
nuclear leukocytes in synovial fluid, (e) growth of the
same microorganism in at least two cultures of syn-
ovial fluid, peri-prosthetic tissue and/or sonication
fluid. Patients were classified into acute postoperative
(≤1 month after implantation), acute hematogenous
(≤3 weeks of infectious symptoms), and chronic PJI
(all other situations) [20]. As a rule, patients with PJI
were managed according to an established algorithm
[21] with debridement and implant retention (DAIR),
one-stage or two-stage procedures, respectively [22].
Statistics
A Shapiro-Wilk test for normality was performed to de-
termine whether continuous data were normally distrib-
uted. All data were non-normal distributed and were
presented as median and range. Mann Whitney rank
sum test was used for comparison of two continuous
(but non-normal distributed) variables, Chi Square or
exact Fisher test for comparison of categorical variables.
Conclusions about ASA Score were considered with re-
gard to two consolidated classes: First class includes
ASA Score I and II versus second class with ASA Score
III and IV. A P-value of ≤ 0.05 was considered to be sta-
tistically significant. Data were analyzed using IBM SPSS
Statistics Version 23.
Results
The minimum follow-up was two years; no patient was
lost to follow-up. None of the patients was treated with
antibiotics for suspected PJI before evaluation by the
interdisciplinary infection team. Of all 1104 THA, 23
(2.1 %) had PJI during the follow-up period.
Acute postoperative PJI (median 17 days, range 13 to
30 days postoperative) was diagnosed in 11 THA, 8 in
the DAA- and 3 in the LAT-group. Three THA had
acute hematogenous PJI (3.5, 5 and 8 months, respect-
ively, after implantation). All THA with acute PJI were
treated with DAIR, mostly with exchange of the modular
parts of the device. Nine THA had chronic PJI (median
11.4, range 1.5 to 47 months after implantation). Two
were treated with DAIR within the first 50 days after im-
plantation, five were treated with one-stage exchange
and two with two-stage exchange. At the final follow-up,
no patient with treatment for PJI had signs of persist-
ence of infection (Table 3).
As we wanted to analyze, whether there is an increased
risk for exogenous PJI with the DAA, we excluded the
three cases with hematogenous PJI (2 DAA, 1 LAT) from
further analysis. The rate of exogenous PJI was similar in
both groups, namely 14/700 (2.0 %) in the DAA- and 6/
404 (1.5 %) in the LAT-group (P = 0.54). Five of the 34 pa-
tients treated with the LAT-approach during the DAA-
period suffered from a PJI; one was operated from lateral
due to severe adipositas (BMI 45 kg/m2, UPI 883), three
due to skin irritations in the groin making an DAA ap-
proach impossible (UPI 599, 1100, 1121), and one because
no DAA trained surgeon was available (UPI 453). Table 3
summarizes patient characteristics, microorganisms, type
of infection and surgical treatment of all patients with
PJI. The spectrum of microorganisms was different in
the two groups. Only patients with the DAA had PJI
caused by gramnegative bacilli (5/14 vs 0/6, P = 0.26).
Table 1 Study population
DAA
n = 700 (63 %)
LAT




Age (median, SD) 71 (10.6) 71 (±10.6) 71 (±10.6) n.s.
Male 369 (53 %) 212 (53 %) 581 (53 %) n.s.
BMI (mean, SD) 26.6 (4.2) 27.2 (5.2) 26.8 (4.6) 0.009
ASA I and II 575 (82 %) 338 (84 %) 913 (83 %) n.s.
Primary
osteoarthritis
644 (92 %) 375 (93 %) 1019 (92 %) n.s.
Head necrosis 44 (6 %) 16 (4 %) 60 (5 %)
Inflammation (RA) 7 (1 %) 2 (0.5 %) 9 (0.8 %)
Other indications 5 (1 %) 11 (3 %) 16 (2 %)
DAA direct anterior approach, LAT lateral approach, BMI body mass index
(kg/m2), ASA American Society of Anesthesiologist, RA rheumatoid arthritis
Table 2 Type of implants
Implant Number Percent
Cups RM and RM vitamys (Mathys) 615 56 %
Selexys TH+ (Mathys) 174 16 %
Allofit (Zimmer) 261 24 %
PE cem 24 2 %
Others 30 3 %
Uncemented stems TwinSys (Mathys) 400 36 %
Avenir (Zimmer) 84 8 %
CBC (Mathys)/CLS (Zimmer) 182 16 %
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In addition, in the DAA-group, the fraction of pa-
tients with polymicrobial infection was somewhat
higher than in the LAT-group (7/14 vs 2/6, P = 0.64).
Six out of 7 polymicrobial PJI in the DAA-group were
caused either by gramnegative bacilli or Enterococcus
faecalis, which reflects the inguinal microbiome.
Patients with PJI had a higher BMI than those without
(median 33.3, range 19 to 46 vs median 26.8, range 17 to
55 vs; P < 0.001) and a higher ASA class (P < 0.001).
However, they did not differ in operation time (median
116 [70 to 223] vs median 109 [44 to 287]; P = 0.20),
gender (P = 0.83), age (median 74 [47 to 88] years vs me-
dian 71 [27 to 93] years; P = 0.24) and blood loss (median
650 [200 to 1300] ml vs median 600 [30 to 3600] ml,
P = 0.48). Patients in the DAA group had a lower
BMI (P = 0.01) as compared to the LAT-group (Table 1).
In addition, they had less blood loss (median 500 [95 to
3600] ml vs median 700 [30 to 2800] ml, P < 0.001) and a
shorter operating time (median 106 [44 to 236] minutes
vs median 114 [49 to 287] minutes, P < 0.001).
Discussion
The presence of an implant increases the risk for infec-
tion more than 100’000fold [23, 24]. Therefore, the
perioperative bacterial load around the incision site is a
crucial risk factor for infection. Three years after
switching from LAT to DAA as the routine approach,
we observed a clustering of early infections with an un-
usual spectrum of microorganisms. We therefore asked
the questions, whether in patients undergoing THA,
the DAA, being located closer to the groin, would in-
crease the rate of PJI, and whether the spectrum of
Table 3 Patient characteristics, microorganisms, type of infection and surgical treatment of all episodes with PJI
UPI Age Gender BMI ASA Approach Microorganisms Type of PJIa Time after
implantation [d]
Treatment
874 83 male 34.3 3 DAA S. epidermidis, Proteus mirabilis 1 13 DAIR




1028 56 male 32.4 2 DAA S. aureus 1 15 DAIR
987 77 male 33.8 3 DAA S. epidermidis, S. haemolyticus,
Aerococcus sp., Acinebacter sp.
1 18 DAIR
812 66 male 29.0 3 DAA S. epidermidis 1 20 DAIR
709 68 female 37.7 2 DAA S. epidermidis 1 21 DAIR
932 88 male 26.0 3 DAA S. aureus, Citrobacter freundii 1 28 DAIR
978 71 female 36.8 3 DAA S. epidermidis 1 30 DAIR
840 76 female 37.8 3 DAA S. epidermidis, Gr.B Streptococcus,
Morganella morganii
3 50 DAIR
532 83 female 32.9 3 DAA Gr.G Streptoccus 2 107 DAIR
572 75 female 26.2 3 DAA CNS, Propionibacterium acnes 3 129 1-stage exchange
1236 73 female 27.3 2 DAA S. lugdunensis 2 160 DAIR
440 72 female 36.3 2 DAA CNS, S. epidermidis, Enterococcus
faecalis, Propionibacterium sp.
3 347 2-stage exchange
1162 47 female 19.1 2 DAA S. aureus 3 386 1-stage exchange
835 83 male 29.6 2 DAA Finegoldia magna 3 416 2-stage exchange
717 74 male 27.1 1 DAA Streptococcus sanguinis 3 1431 1-stage exchange
883 63 female 45.6 2 LAT S. epidermidis, Enterococcus
faecalis, S. warneri
1 17 DAIR
599 84 male 33.3 3 LAT S. epidermidis, Bacillus sp. 1 17 DAIR
109 73 female 29.0 2 LAT CNS 1 17 DAIR
1121 64 male 36.6 2 LAT Actinomyces sp. 3 46 DAIR
1100 65 male 40.3 3 LAT Streptococcus sp. 2 238 DAIR
453 81 male 28.3 3 LAT CNS 3 306 1-stage exchange
84 74 male 27.7 1 LAT CNS 3 1124 1-stage exchange
Abbreviations: a1: acute postoperative PJI, 2: acute hematogenous PJI, 3: chronic PJI, DAIR debridement and retention including exchange of mobile parts, PJI
periprosthetic joint infection, BMI body mass index, ASA American Society of Anesthesiologist score, UPI unique patient identification number, CNS coagulase
negative staphylococci
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microorganisms would differ in patients with the DAA
as compared to those with the LAT-approach.
The published incidence of PJI after THA is 0.5 to 3 %
[1]. In patients with DAA, an incidence of up to 3 % is
described [13, 25]. Because patients undergoing debride-
ment without exchange of mobile parts, as well as those
with exclusive suppressive therapy might not appear in
registers, the published infection rates may be underesti-
mated [1]. We compared the rate of PJI in infection rate
in patients with DAA vs those with LAT in our cohort
of patients, including all consecutive patients undergoing
elective THA and any kind of infection treatment. None
of the suspected early exogeneous PJI was treated as a
superficial infection with antibiotics alone. In case of
wound healing disturbances, PJI was actively searched
with an additional debridement and microbiological
sampling. Our observed infection rate seems rather high
but still it was within the published range. We controlled
our clinical routines and found no mitigating factors that
might contribute to a higher risk of infection [7]. Fur-
thermore the rate of implant exchange due to PJI was
comparable to register data thus the used DAA generally
might not be considered as risk factor for PJI [26, 27].
But larger RCT trials should be performed to compare
the DAA to established lateral and posterior approaches.
In our series, 87.0 % of the patients with PJI had either
acute or chronic exogenous infection independent from the
approach. Thus, intraoperative contamination or implant
contamination in the early postoperative time was by far
the most frequent mechanism of infection. The overall in-
fection rate was not different in the two groups. Thus, in
contrast to published data [26] the introduction of the new
approach was rather safe, which is probably due to the fact
that the first 100 cases with the new incision site were oper-
ated by the same two experienced surgeons [15]. Exogen-
ous polymicrobial infections were somewhat more frequent
in the DAA- as compared to the LAT-group (50.0 % vs
33.3 %, P = 0.64), however, this difference was statistically
not significant. Since in our previous cohort study of PJI
from 1984–2001, the fraction of patient with polymicrobial
PJI was only 12.7 % (8/63) [28] in patients treated with the
LAT approach, the DAA might be a risk factor for polymi-
crobial PJI in a larger cohort. Polymicrobial PJI are mainly
observed in patients with wound healing disturbances.
Thus, these infections are acquired during the early postop-
erative period. The risk of polymicrobial PJI might be low-
ered for DAA by a more lateral skin incision keeping more
distance to the groin and the use of modern dressing tech-
niques avoiding skin folds that might cause sweating and
contamination. In addition, this modified approach reduces
the risk for damaging the cutaneal femoral lateral nerve too
[29]. We adopted this technique during the observation
period after observing a clustering of infections and felt that
there was no persistence of that problem.
The mean BMI and ASA score of the studied patients
did not differ from published populations, indicating
that our cohort represents a normal population of THA
patients. As in previously published studies, patients
with a higher BMI, a higher ASA score and longer oper-
ating time had a significantly increased risk of PJI in our
entire cohort. These patients are at risk irrespective of
the incision site [12, 13].
The main limitation of our study is the lack of
randomization concerning the approach. A possible selec-
tion bias was introduced by operating 34 patients with the
lateral approach, during the period when we already
switched to the DAA. Five of the patients treated with the
LAT-approach during the DAA-period suffered from PJI,
three of them had skin irritations in the groin making
DAA not suitable. This might be confounding, and it can-
not be excluded that the infection rate of the DAA group
might have been higher, if all consecutive patients were
operated with the DAA. An additional limitation is the
relatively low number of patients, as compared to register
studies with several thousands of patients. Thus, the study
is likely to be underpowered leading to a lack of significant
differences. The increased risk for gramnegative and poly-
microbial infection should be verified, when data from lar-
ger cohorts will be available. At the present time, such
data are missing, since minimal invasive approaches have
been popularized only recently in Europe and the US.
Strengths of our study are the complete follow-up of all
patients, the completeness of data on ASA, BMI and
causative microorganisms and the absence of undiagnosed
PJI due to unrecognized suppressive therapy without thor-
ough diagnostic work-up. This is an advantage in com-
parison to register data, which may not include all
infected patients, because patients with antibiotic suppres-
sion or debridement might not be reported [1]. Another
strength is the availability of a specialized interdisciplinary
team caring for all patients with orthopedic infection.
Thus, the risk for underreporting the early and mid-term
infection risk of our patients is very low.
Conclusions
The introduction of the DAA did not increase the risk
of PJI. However a tendency for a higher fraction of poly-
microbial and gramnegative PJI was observed in patients
treated with the DAA.
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